Sievert
Andreas Maximilian Sievert, Linkoping SE
Patent application number | Description | Published |
---|---|---|
20140267254 | Accurate Image Alignment to a 3D Model - Methods and devices for acquiring, and aligning, an image with a textured three-dimensional (3D) model are described. In one implementation, aligning can include rendering an image in the 3D model at an estimated pose and then aligning the acquired image with the rendered image. In another implementation, aligning can include projecting the acquired image onto the 3D model at an estimated pose and then aligning the projected acquired image with the textured 3D model. In still another embodiment, aligning can include projecting the acquired image onto the textured 3D model, rendering a first image in the original 3D model and a second image in the 3D model onto which the acquired image has been projected, and then aligning the first and second images. | 09-18-2014 |
Arvid Sievert, Esslingen DE
Patent application number | Description | Published |
---|---|---|
20090301430 | Method for metering fuel into combustion chambers of an internal combustion engine - A method and control unit for metering fuel into at least one combustion chamber of an internal combustion engine comprising at least one pilot injection and one main injection per combustion cycle, combustion features being detected and an effect of a fuel quantity injected prior to the main injection being ascertained from the combustion features. An actual value of a combined effect of at least two pilot injections per combustion cycle is ascertained and the actual value is regulated to a setpoint value via an intervention on at least one of the pilot injections. | 12-10-2009 |
20120272938 | METHOD FOR DETERMINING THE LOW PRESSURE EXHAUST GAS RECIRCULATION MASS FLOW IN THE AIR SYSTEM OF AN INTERNAL COMBUSTION ENGINE - In a method for determining a low pressure exhaust gas recirculation mass flow | 11-01-2012 |
Frank Sievert, Allmendingen DE
Patent application number | Description | Published |
---|---|---|
20120195966 | ORAL DOSAGE FORM FOR MODIFIED RELEASE COMPRISING A JAK3 INHIBITOR - The invention essentially relates to oral dosage forms comprising a JAK3 inhibitor, preferably tasocitinib, suitable for modified release, and processes of preparing such oral dosage forms. | 08-02-2012 |
20130344149 | Oral Dosage Forms for Modified Release Comprising Tasocitinib - The invention essentially relates to oral dosage forms comprising a JAK3 inhibitor, preferably tasocitinib, suitable for modified release, and processes of preparing such oral dosage forms. | 12-26-2013 |
20150246043 | ORAL DOSAGE FORMS FOR MODIFIED RELEASE COMPRISING RUXOLITINIB - The invention essentially relates to oral dosage forms comprising a JAK kinase inhibitor, preferably Ruxolitinib, suitable for modified release, and processes of preparing such oral dosage forms. | 09-03-2015 |
Karl-Dietrich Sievert, Reutlingen DE
Patent application number | Description | Published |
---|---|---|
20120221015 | SACRAL NEUROMODULATOR - The invention relates to a stimulation electrode for a stimulation device for stimulating organs in the case of spinal paraplegia, more particularly in the case of detrusor sphincter dyssynergia, including an electrode shaft, at one end of which an electrode tip is arranged for emitting a stimulation signal and at the other end of which a connection region is provided for a signal line, and also at least one fixing mechanism for fixing the position of the electrode shaft in the surrounding tissue along the longitudinal axis of said electrode shaft, fixing mechanism having at least one holding member preventing a withdrawal and at least one holding member preventing an advance. | 08-30-2012 |
Mario Sievert, Rotgesbuttel DE
Patent application number | Description | Published |
---|---|---|
20140147066 | BEARING ARRANGEMENT FOR A SHAFT OF A TURBINE WHEEL - The invention relates to a bearing arrangement for a shaft ( | 05-29-2014 |
Roland Sievert, Ratingen DE
Patent application number | Description | Published |
---|---|---|
20110100008 | Method and Device for Operating a Steam Power Station Comprising a Steam Turbine and a Process Steam Consumer - A method for operating a steam power station is provided. The steam turbine power station includes at least one steam turbine and a process steam consumer, wherein a steam mass flow is subdivided into a first partial mass flow and a second partial mass. In a first operating state, the first partial mass flow is supplied to the steam turbine and the second partial mass flow is supplied to the process steam consumer. In a second operating state, at least part of the second partial mass flow is supplied to the steam turbine at least after the first turbine stages. A steam power station is also provided. | 05-05-2011 |
Scott Sievert, Erie CA
Patent application number | Description | Published |
---|---|---|
20130166327 | SYSTEM AND METHOD HAVING A HIERARCHICAL MODEL WITH OVERRIDE CAPABILITY FOR GENERATING A FLEXIBLE INSURANCE PLAN - A system and method for implementing an insurance plan to coordinate an adjudication of a submitted claim corresponding to the plan. The plan includes a people model and a benefit model, such as hierarchical trees combined by a plurality of policies. The system and method comprise assigning a first predefined inheritance of global attributes to coupled elements of the people tree and assigning a second predefined inheritance of global attributes to coupled elements of the benefits tree. The system and method also assigning a local administration rule for at least one local attribute of the trees, the assignment between a selected people element of the people tree and a selected benefit element of the benefits tree. The local administration rule overrides the corresponding global attributes of the selected elements, such that resolution of the global attributes with the local attributes for the selected elements provides a rule set for adjudication of the submitted claim. | 06-27-2013 |
Scott J. Sievert, Erieu CA
Patent application number | Description | Published |
---|---|---|
20090157433 | System and method having a hierarchical model with override capability for generating a flexible insurance plan - A system and method for implementing an insurance plan to coordinate an adjudication of a submitted claim corresponding to the plan. The plan includes a people model and a benefit model, such as hierarchical trees combined by a plurality of policies. The system and method comprise assigning a first predefined inheritance of global attributes to coupled elements of the people tree and assigning a second predefined inheritance of global attributes to coupled elements of the benefits tree. The system and method also assigning a local administration rule for at least one local attribute of the trees, the assignment between a selected people element of the people tree and a selected benefit element of the benefits tree. The local administration rule overrides the corresponding global attributes of the selected elements, such that resolution of the global attributes with the local attributes for the selected elements provides a rule set for adjudication of the submitted claim. | 06-18-2009 |
Sebastian Sievert, Munich DE
Patent application number | Description | Published |
---|---|---|
20150381156 | SYSTEM FOR DIGITALLY CONTROLLED EDGE INTERPOLATOR LINEARIZATION - This application discusses, among other things, an interpolator architecture for digital-to-time converters (DTCs). In an example, an interpolator can include interpolation cells and retention cells configured provide an interpolated output based on at least two offset clock signals. In certain examples, an example interpolator can provide contention free control of the interpolator output with improved noise immunity. | 12-31-2015 |
William Sievert, Victoria AU
Patent application number | Description | Published |
---|---|---|
20100075299 | DETECTION AND USE OF ANTIVIRAL RESISTANCE MUTATIONS - The present invention relates generally to viral variants exhibiting reduced sensitivity to particular agents and/or reduced interactivity with immunological reagents. More particularly, the present invention is directed to hepatitis B virus (HBV) variants exhibiting complete or partial resistance to nucleoside or nucleotide analogs and/or reduced interactivity with antibodies to viral surface components including reduced sensitivity to these antibodies. Vaccines and diagnostic assays are also contemplated herein. | 03-25-2010 |
William Sievert, Clayton AU
Patent application number | Description | Published |
---|---|---|
20090053201 | HEPATITIS B VIRAL VARIANTS WITH REDUCED SUSCEPTIBILITY TO NUCLEOSIDE ANALOGS AND USES THEREOF - The present invention relates generally to viral variants exhibiting reduced sensitivity to particular agents and/or reduced interactivity with immunological reagents. More particularly, the present invention is directed to hepatitis B virus (HBV) variants exhibiting complete or partial resistance to nucleoside or nucleotide analogs and/or reduced interactivity with antibodies to viral surface components including reduced sensitivity to these antibodies. The present invention further contemplates assays for detecting such viral variants, which assays are useful in monitoring anti-viral therapeutic regimens and in developing new or modified vaccines directed against viral agents and in particular HBV variants. The present invention also contemplates the use of the viral variants to screen for and/or develop or design agents capable of inhibiting infection, replication and/or release of the virus. | 02-26-2009 |
20090081637 | Hepatitis B Viral Variants With Reduced Susceptibility To Nucleoside Analogs And Uses Thereof - The present invention relates generally to viral variants exhibiting reduced sensitivity to particular agents and/or reduced interactivity with immunological reagents. More particularly, the present invention is directed to hepatitis B virus (HBV) variants exhibiting complete or partial resistance to nucleoside or nucleotide analogs and/or reduced interactivity with antibodies to viral surface components including reduced sensitivity to these antibodies. The present invention further contemplates assays for detecting such viral variants, which assays are useful in monitoring anti-viral therapeutic regimens and in developing new or modified vaccines directed against viral agents and in particular HBV variants. The present invention also contemplates the use of the viral variants to screen for and/or develop or design agents capable of inhibiting infection, replication and/or release of the virus. | 03-26-2009 |
20090081667 | Viral Variants With Altered Susceptibility To Nucleoside Analogs And Uses Thereof - The present invention relates generally to viral variants exhibiting reduced sensitivity to particular agents and/or reduced interactivity with immunological reagents. More particularly, the present invention is directed to hepatitis B virus (HBV) variants exhibiting complete or partial resistance to nucleoside analogs and/or reduced interactivity with antibodies to viral surface components including reduced sensitivity to these antibodies. The present invention further contemplates assays for detecting such viral variants, which assays are useful in monitoring anti-viral therapeutic regimens and in developing new or modified vaccines directed against viral agents and in particular HBV variants. The present invention also contemplates the use of the viral variants to screen for agents capable of inhibiting infection, replication and/or release of the virus. | 03-26-2009 |
20100221746 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISEASE - The present invention relates to pharmaceutical compositions for the treatment and/or prophylaxis of disease associated with fibrosis in a vertebrate, said composition comprising at least one activin antagonist, and optionally a pharmaceutically acceptable carrier, adjuvant and/or diluent. The invention also relates to methods of treatment of disease associated with fibrosis in a vertebrate, as well as methods for diagnosing such conditions, and kits therefor. | 09-02-2010 |
20100304392 | HEPATITIS B VIRAL VARIANTS WITH REDUCED SUSCEPTIBILITY TO NUCLEOSIDE ANALOGS AND USES THEREOF - The present invention relates generally to viral variants exhibiting reduced sensitivity to particular agents and/or reduced interactivity with immunological reagents. More particularly, the present invention is directed to hepatitis B virus (HBV) variants exhibiting complete or partial resistance to nucleoside or nucleotide analogs and/or reduced interactivity with antibodies to viral surface components including reduced sensitivity to these antibodies. The present invention further contemplates assays for detecting such viral variants, which assays are useful in monitoring anti-viral therapeutic regimens and in developing new or modified vaccines directed against viral agents and in particular HBV variants. The present invention also contemplates the use of the viral variants to screen for and/or develop or design agents capable of inhibiting infection, replication and/or release of the virus. | 12-02-2010 |
20110189652 | VIRAL VARIANTS WITH ALTERED SUSCEPTABILITY TO NUCLOESIDE ANALOGS AND USES THEREOF - The present invention relates generally to viral variants exhibiting reduced sensitivity to particular agents and/or reduced interactivity with immunological reagents. More particularly, the present invention is directed to hepatitis B virus (HBV) variants exhibiting complete or partial resistance to nucleoside analogs and/or reduced interactivity with antibodies to viral surface components including reduced sensitivity to these antibodies. The present invention further contemplates assays for detecting such viral variants, which assays are useful in monitoring anti-viral therapeutic regimens and in developing new or modified vaccines directed against viral agents and in particular HBV variants. The present invention also contemplates the use of the viral variants to screen for agents capable of inhibiting infection, replication and/or release of the virus. | 08-04-2011 |
William Sievert, Canterbury AU
Patent application number | Description | Published |
---|---|---|
20140296504 | HEPATITIS B VIRAL VARIANTS WITH REDUCED SUSCEPTIBILITY TO NUCLEOSIDE ANALOGS AND USES THEREOF - The present invention relates generally to viral variants exhibiting reduced sensitivity to particular agents and/or reduced interactivity with immunological reagents. More particularly, the present invention is directed to hepatitis B virus (HBV) variants exhibiting complete or partial resistance to nucleoside or nucleotide analogs and/or reduced interactivity with antibodies to viral surface components including reduced sensitivity to these antibodies. The present invention further contemplates assays for detecting such viral variants, which assays are useful in monitoring anti-viral therapeutic regimens and in developing new or modified vaccines directed against viral agents and in particular HBV variants. The present invention also contemplates the use of the viral variants to screen for and/or develop or design agents capable of inhibiting infection, replication and/or release of the virus. | 10-02-2014 |